Syra Health Corp [SYRA] stock prices are up 19.24% to $0.60 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The SYRA shares have gain 36.43% over the last week, with a monthly amount glided 51.45%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
The stock price of Syra Health Corp [SYRA] has been fluctuating between $0.34 and $8.37 over the past year. Syra Health Corp [NASDAQ: SYRA] shares were valued at $0.60 at the most recent close of the market.
Analyzing the SYRA fundamentals
The Syra Health Corp [NASDAQ:SYRA] reported sales of 7.74M for trailing twelve months, representing a surge of 42.49%. Gross Profit Margin for this corporation currently stands at 0.12% with Operating Profit Margin at -0.55%, Pretax Profit Margin comes in at -0.55%, and Net Profit Margin reading is -0.55%. To continue investigating profitability, this company’s Return on Assets is posted at -0.96, Equity is -1.32 and Total Capital is -1.2. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.1.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.4956 points at the first support level, and at 0.3913 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.6621, and for the 2nd resistance point, it is at 0.7243.
Ratios To Look Out For
It’s worth pointing out that Syra Health Corp [NASDAQ:SYRA]’s Current Ratio is 4.63. Also, the Quick Ratio is 4.63, while the Cash Ratio stands at 3.07. Considering the valuation of this stock, the price to sales ratio is 0.76, the price to book ratio is 1.77.
Transactions by insiders
Recent insider trading involved Prasad Priya, CFO and COO, that happened on Sep 12 ’24 when 5303.0 shares were purchased. CFO and COO, Prasad Priya completed a deal on Feb 08 ’24 to sell 500.0 shares.
